In a complementary way, a clinical study in Spain observed that ACE I/D polymorphisms were related to viral infection, depending on clinical hypertension severity (Gómez et al., 2020), indicating that both genetic and clinical factors are simultaneously implicated in COVID-19 outcomes. This evidence concerns the gene ACE and Hypertension.